Quantification of pramipexole in human plasma by liquid chromatography tandem mass spectrometry using tamsulosin as internal standard

Biomedical Chromatography

Volumn 21, Issue 11, 2007, Pages 1151-1158

  Nirogi, Ramakrishna V S ^a   Kandikere, Vishwottam ^a   Shrivastava, Wishu ^a   Mudigonda, Koteshwara ^a   Maurya, Santosh ^a   Ajjala, Devender ^a  

^a SUVEN LIFE SCIENCES LTD   (India)

Author keywords

Human plasma; Liquid chromatography tandem mass spectrometry; Pharmacokinetic study; Pramipexole

Indexed keywords

BIOCHEMISTRY; MASS SPECTROMETRY; PHARMACOKINETICS; PLASMA (HUMAN);

ANALYTES; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION TANDEM MASS SPECTROMETRY; HUMAN PLASMA SAMPLES; HUMAN PLASMAS; INTERNAL STANDARDS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; LIQUID-LIQUID EXTRACTION; PHARMACOKINETIC STUDIES; PRAMIPEXOLE;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

PRAMIPEXOLE; PROTON; TAMSULOSIN;

ACCURACY; ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG STABILITY; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LIQUID LIQUID EXTRACTION; NORMAL HUMAN; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SEPARATION TECHNIQUE; SINGLE DRUG DOSE; STANDARD; STORAGE TEMPERATURE; TANDEM MASS SPECTROMETRY; TIME; VOLUNTEER;

EID: 36749101414     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.864     Document Type: Article

References (10)

1. Bennett JP and Piercey MF. Pramipexole - a new dopamine agonist for the treatment of Parkinson's disease. Journal of the Neurological Sciences 1999; 163: 25.
2. Lau YY, Hanson GD and Ichhpurani N. Determination of pramipexole (U-98,528) in human plasma and urine by high-performance liquid chromatography with electrochemical and ultraviolet detection. Journal of Chromatography B 1996a; 683: 217.
3. Lau YY, Selenka JM, Hanson GD, Talaat R and Ichhpurani N. Determination of pramipexole (U-98,528) in human plasma by high-performance liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry. Journal of Chromatography B 1996b; 683: 209.
4. Matuszewski BK, Constanzer ML and Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Analytical Chemistry 2003; 75: 3019.
5. 2-receptor agonist. European Journal of Pharmacology 1992; 215: 161.
6. 4 receptors. European Journal of Pharmacology 1995; 290: 29.
7. 3-preferring dopamine agonist: comparison to other dopamine agonists. European Journal of Pharmacology 1996; 312: 35.
8. Relja M and Klepac N. A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease. Journal of Neurological Sciences 2006; 248: 251.
9. Shah VP, Midha KK, Dighe S, McGilveray IJ, Skelly JP, Yacobi A, Layloff T, Vishwanathan CT, Cook CE and McDowall RD. Analytical methods validation: bioavailabihity, bioequivalence and pharmacokinetic studies. Conference report. European Journal of Drug Metabolism and Pharmacokinetics 1991; 16: 249.
10. Wright CE, Sisson TL, Ichhpurani AK and Peters GR. Steady-state pharmacokinetic properties of pramipexole in healthy volunteers. Journal of Clinical Pharmacology 1997; 37: 520.